Medical News

RSS

Surgeon General Benjamin: U.S. needs more minority doctors

The new U.S. Surgeon General called for an increased effort to recruit more minority doctors Thursday in a speech in Atlanta.

4 Dec 2009

Overview of the important research and treatments in ADHD

Worldwide longitudinal studies performed since the 1970s have clearly shown that ADHD persists into adulthood. These findings have stimulated researchers to develop the therapeutic approaches for adult patients, especially in European countries where scientific and clinical interest in ADHD has increased.

4 Dec 2009

Public Campaign Action Fund names Sen. Richard Burr as its final 'Insurance Puppet'

Public Campaign Action Fund, a national campaign finance watchdog group, named Sen. Richard Burr (R-N.C.) its final "Insurance Puppet" in an online advertising campaign targeting North Carolina and Washington, D.C.

4 Dec 2009

Some Doctors' groups breaking with AMA to oppose health bill

Doctors are divided over health care reform with an increasing number of them expressing opposition.

4 Dec 2009

FNAC plays an increased role in the diagnosis of bone lesions

In recent years, fine-needle aspiration cytology (FNAC) has become a widely accepted procedure in the diagnosis of bone lesions. Rapid progress in immunocytochemistry and molecular genetics has increased the role of FNAC in the investigation of primary bone lesions.

4 Dec 2009

Senate's efforts on health care being slowed by other issues

The Wall Street Journal: "The Senate's slow-moving health bill is colliding with other legislative priorities on the economy, raising chances that Democrats won't meet their goal of pushing a health-care overhaul through the chamber this month." Though some forward progress was evidenced on Thursday when the chamber, for the first time since floor consideration of the health bill began, voted on amendments.

4 Dec 2009

Surgeon General calls for more minority doctors to join physician workforce

The new U.S. Surgeon General called for an increased effort to recruit more minority doctors Thursday in a speech in Atlanta.

4 Dec 2009

Watson Laboratories files an ANDA for generic version of Rozerem

Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.

4 Dec 2009

Fact checking lawmakers' claims about health bills

NPR began a series called "Is That So?": "As the debate about the health overhaul bill goes on (and on and on) you might find that sometimes what one Senator says seems to be the exact opposite of the next." In the first installment, NPR's Julie Rovner examined Sen. Christopher Dodd's statement: "On the day this bill is enacted, health insurance becomes a buyer's market, not a seller's market. And that's as American as apple pie," and found that "it may be so eventually, but definitely not on the day the bill is enacted."

4 Dec 2009

Pfizer to present study findings from its expanded breast cancer portfolio

Pfizer Oncology announced today that it will be presenting study findings evaluating several compounds including those from its newly expanded breast cancer portfolio following the recent acquisition of Wyeth, focusing on the needs of multiple breast cancer patient populations at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) being held December 9 – 13.

4 Dec 2009

Cyberonics' FDA-approved VNS Therapy to be featured at the AES meeting

Cyberonics, Inc. announced today that Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, will be featured in 14 presentations at the American Epilepsy Society's (AES) Annual Meeting, taking place December 4-8 at the Hynes Convention Center in Boston, Massachusetts.

4 Dec 2009

Preclinical data of Curis' HSP 90 inhibitor published

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that preclinical data related to CUDC-305, the company’s Heat Shock Protein (HSP) 90 inhibitor, was published online this week in Molecular Cancer Therapeutics.

4 Dec 2009

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

4 Dec 2009

Orthofix International announces the launch of its FUSION Lateral OA Brace

Orthofix International announced today that its sports medicine division, BREG, has expanded its successful line of FUSION® functional knee braces by introducing the FUSION® Lateral OA Brace, which features an ultra-thin low-profile hinge designed for individuals suffering from lateral compartment osteoarthritis (OA).

4 Dec 2009

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta™ surgical lead for neurostimulation therapy. Unveiled at the annual North American Neuromodulation Society meeting, the Penta lead is the first of its kind, featuring the smallest electrodes in the market arranged in five columns.

4 Dec 2009

IMF to stage presentation on multiple myeloma at ASH annual meeting

The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said presentations at the annual meeting of the American Society of Hematology (ASH) will cover all stages of multiple myeloma, a major milestone in treating this and related cancers.

4 Dec 2009

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") announced today that the US Patent and Trademark Office has allowed its patent application on a system for automation of the initial stages of the manufacture of the Company's DCVax® therapeutic cancer vaccines.

4 Dec 2009

Watchdog group names Sen. Chuck Grassley as third 'Insurance Puppet'

Public Campaign Action Fund, a national campaign finance watchdog group, named Sen. Chuck Grassley (R-Iowa) its third "Insurance Puppet" in an online advertising campaign targeting Iowa and Washington, D.C.

4 Dec 2009

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur more often in people who said they had been diagnosed with epilepsy versus those without an epilepsy diagnosis, according to a survey of approximately 173,000 households across the U.S.

4 Dec 2009

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

PuriCore, the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, was named as winner of the Emerging Life Sciences Company of the Year award, at the Eastern Technology Council’s 17th annual Enterprise Awards gala.

4 Dec 2009